Public Employees Retirement System of Ohio Sells 5,746 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Public Employees Retirement System of Ohio trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 11.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 43,277 shares of the company's stock after selling 5,746 shares during the period. Public Employees Retirement System of Ohio's holdings in Henry Schein were worth $2,995,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Private Management Group Inc. lifted its holdings in shares of Henry Schein by 5.7% in the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after purchasing an additional 18,882 shares in the last quarter. Equitable Trust Co. purchased a new stake in Henry Schein in the 4th quarter worth about $417,000. Savant Capital LLC increased its holdings in Henry Schein by 43.9% in the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after acquiring an additional 1,420 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in Henry Schein by 29.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock worth $1,113,000 after acquiring an additional 3,650 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Henry Schein by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company's stock worth $82,464,000 after acquiring an additional 16,616 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Price Performance

Shares of HSIC traded down $0.18 during trading hours on Wednesday, reaching $70.39. 1,210,614 shares of the company's stock traded hands, compared to its average volume of 1,683,392. The stock has a market cap of $8.57 billion, a PE ratio of 28.97, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm's 50 day simple moving average is $67.71 and its 200-day simple moving average is $71.68. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter last year, the company posted $1.10 EPS. Equities analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Barrington Research cut their target price on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Piper Sandler cut their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Wells Fargo & Company cut their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Finally, Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $79.30.

Insider Buying and Selling

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.